Fundraising Fox
/Companies
Sign in

Creyon

3 known investors

Find your way into Creyon

Sign up to see every warm intro you have to Creyon

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Creyon team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

MLMatthew Levy
Matthew LevyCo-founderMatthew Levy is a nucleic acid and biochemist with over 20 years of experience in oligonucleotide therapeutics. He was an Associate Professor of Biochemistry at Albert Einstein College of Medicine, where he led a research laboratory focused on aptamer development and protein engineering, and subsequently served as VP of Discovery at Vitrisa Therapeutics before co-founding Creyon.

Investors · 3

Tenmilelisted by Tenmile
DCVC BioreportedPalo Alto

How we know: funding news · Not right? Tell us

Frequently asked questions

What does Creyon do?
Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.
Who founded Creyon?
Creyon was founded by Matthew Levy.
Who are Creyon's investors?
Creyon's investors include Lux Capital, Tenmile, DCVC Bio.